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Context. Uremic pruritus, or itch, is common in people with chronic kidney disease (CKD) and has a negative impact on
their lives and well-being. However, for reasons currently unknown, itch often remains unreported and therefore untreated.
Objectives. To explore reasons for underreporting of itch to provide pointers for improving itch reporting and
management in people with CKD.
Methods. We interviewed adult patients with CKD who self-reported experiencing itching in the last three years (n ¼ 25),
nephrologists (n ¼ 10), and nurses (n ¼ 12) from three kidney services in the U.K. Topic guides were informed by previous
studies and a theoretical model of self-regulation. We conducted a thematic analysis of verbatim transcripts using framework
analysis.
Results. We identified the following three main themes reflecting factors that may influence whether itch is reported:
knowledge on causes and treatment of itch (lack of awareness of the relationship between itch and CKD, and lack of
knowledge of treatment options); attitudes toward importance of itch as a health issue (patients’ and clinicians’ attitudes);
and prompts for itch assessment during consultations (routine practice, itch as a marker, and itch severity).
Conclusion. Underreporting of itch is related to patients being unaware of its causes, accepting it as something to live with,
prioritizing other health issues, and the length and timing of consultations. Health care professionals’ assessment and
management of itch vary widely and are not necessarily evidence-based. Better patient information, development of clinical
practice guidelines, and incorporation of routine symptom assessments into care may improve itch reporting and
management in people with CKD. J Pain Symptom Manage 2019;58:578e586.  2019 The Authors. Published by Elsevier Inc.
on behalf of American Academy of Hospice and Palliative Medicine. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Symptom burden is high in people with chronic kid-
ney disease (CKD).1,2 This negatively affects patients’
quality of life, and increases the risk of depression
and treatment non-adherence.3e5 Improving symp-
tom management is a research priority for CKD pa-
tients,6 and clinical practice guidelines recommend
it as a key element of CKD care.7e9 But despite their
prevalence, impact and importance, CKD symptoms
often remain unrecognized and untreated.10e12
Uremic pruritus, or itch, is a common, yet often
overlooked CKD symptom, with estimated prevalence
ranging from 25%13 to 44%.14 Although the underly-
ing mechanisms that cause itch in people with
CKD remain poorly understood,15 there are several
recommended nonpharmacologic and pharmaco-
logic treatments available, such as gentle soaps and
moisturizers, topical ointments and gabapentin.16e18
Nonetheless, 20% of severely affected patients in a
large cohort studydthe Dialysis Outcomes and Prac-
tice Patterns Studydwere not treated for itch,12 mir-
roring low treatment rates found in other
studies.11,19 Untreated itch is associated with
disturbed sleep, depression, higher resource use,
and lower general health and quality of life in a
dose-response manner.13,14,20e22
Health care professionals tend to underestimate the
prevalence of itch.12,23,24 One explanation may be that
patients do not always report itch: 17% of severely
affected patients in the Dialysis Outcomes and Prac-
tice Patterns Study said they had never discussed their
itch with a health care professional.12 However, rea-
sons for underreporting of itch in CKD are unknown.
It is also unclear if and how patients’ reporting behav-
iors are influenced by how health care professionals
view, discuss, and manage itch. Therefore, we conduct-
ed a qualitative study that combined patient and
health care professional interviews to better under-
stand why itch is underreported in CKD.Material and Methods
We used the Consolidated Criteria for Reporting
Qualitative Health Research.25
Participant Selection
Patients were eligible if they 1) were under the care
of a nephrologist; 2) self-reported having been both-
ered by itch in the last three years; and 3) understood
and spoke English. For the interviews with health care
professionals, we recruited consultant and trainee ne-
phrologists and renal nurses from three kidney cen-
ters in the U.K. Local research nurses purposively
selected and invited eligible participants, aiming for
a maximum variation in age, gender, treatmentmodality (CKD Stages 1e5, dialysis, and transplanted),
and itch experience (current and past).26
Data Collection
We conducted face-to-face, semi-structured individ-
ual interviews with patients and nephrologists; nurses
participated in focus group interviews. We developed
topic guides using previous studies on barriers to
symptom reporting and management;23,27 the Com-
mon Sense Model (CSM) of self-regulation, which is
a theoretical model of processes underlying the self-
management of symptoms and other health threats
in everyday life;28,29 and input from two patient repre-
sentatives and two nephrologists (HR and JOB). The
patient guide included topics such as the impact of
itch on everyday life, experiences of reporting itch to
health professionals, and reasons for not reporting
itch. For health care professionals, topics were experi-
ences of patients reporting itch, perceived importance
of itch as part of overall kidney care, and approaches
to diagnosing and managing itch. All interviews were
audio-recorded and transcribed verbatim.
Data Analysis
We uploaded transcripts into NVivo (version 11,
QSR International Pty Ltd., Melbourne, Australia,
2014) to support data management and analysis.
The framework method informed a two-stage data
analysis strategy.30 First, we developed and finalized a
matrix that included both theory-driven codes, as
well as those related to emerging themes from the first
15 interview transcripts. To pilot-test and further
refine the matrix, two researchers (GA and SNvdV)
independently coded five patient and three health
care professional interviews, and resolved discrep-
ancies through discussion. For all codes, the inter-
rater agreement between coders was above 80% and
Cohen’s k $ 0.40.31 Second, we used the final matrix
to code the remaining transcripts. We reached data
saturation after analyzing the 21st and 11th patient
and health care professional transcript, respectively.
Codes were described conceptually and discussed by
the research team to identify iteratively cross-cutting
themes between patient and health care professional
interviews (i.e., participants’ triangulation). Once we
agreed on themes and subthemes, input from two pa-
tient representatives aided the interpretation of find-
ings and ensured themes reflected the patients’
perspective (i.e., member checking).Results
Of the 41 patients approached, 25 (61%) agreed to
be interviewed. Reasons for declining participation
were as follows: unable to schedule the interview
Table 1
Participants’ Characteristics
Characteristic Number (%)
Patients
Total N 25 (100)
Male gender 14 (56)
Age, yrs
#50 6 (24)
51e70 9 (36)
>70 10 (40)
Treatment modality
CKD Stages 1e5a 6 (24)
Dialysis 14 (56)
Transplanted 5 (20)
Currently bothered by itch 20 (80)
Health care professionals
Total N 22 (100)
Role
Nephrologist 10 (45)
Renal nurse 12 (55)
Male gender 6 (27)
Years of clinical practice
#10 3 (14)
10e20 5 (23)
>20 2 (9)
Unknownb 12 (55)
Clinical areac
CKD Stages 1e5 6 (24)
Dialysis/Transplant 19 (76)
CKD ¼ chronic kidney disease.
aPatients who were under the care of a nephrologist, but were not on kidney
replacement therapy. Half of the participants in this group were recruited
from low clearance clinics, and the other half from general nephrology
clinics.
bWe did not record the years of clinical practice for nurses participating in the
focus groups.
cSum more than the total N because some health care professionals worked in
more than one area.
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health-related reasons (N ¼ 2). Ten nephrologists
and 12 renal nurses took part in the health care pro-
fessional interviews. Table 1 displays participants’ char-
acteristics. Patient and nephrologist interviews lasted
15 to 72 (mean, 33.6) and 22 to 54 (mean, 33.0) mi-
nutes, respectively. The three focus groups with nurses
took 24, 30, and 33 minutes.
We identified the following three main themes re-
flecting factors that may influence whether patients
discuss itch with their kidney health care team: knowl-
edge on causes and treatment of itch (lack of aware-
ness of the relationship between itch and CKD, and
lack of knowledge of treatment options); attitudes to-
ward the importance of itch as a health issue (patients’
and health care professionals’ attitudes); and prompts
for itch assessment during consultations (routine
practice, itch as a marker, and itch severity). Table 2
and Appendix Table 1 contain illustrative quotations.Knowledge on Causes and Treatment of Itch
Lack of Awareness of the Relationship Between Itch and
CKD. Several patients reported that they had long
been unaware that itch might be a symptom of theirkidney disease, partly because the kidney team had
not mentioned itch as a CKD symptom.
I’ve been itching for two years [.] when I mentioned it [to
the nephrologist, it was because] I had found it in a leaflet
and I thought: ‘that’s the first time I’ve seen it’. (PCe04,
male, 72 years, dialysis)
Instead, patients attributed it to other conditions,
such as dry skin. Accordingly, they sought help from
non-kidney health care professionals, such as general
practitioners (GPs) or dermatologists; nephrologists’
accounts confirmed this by suggesting that many pa-
tients had already discussed itch with their GP before
bringing it up in a consultation with their kidney
team. However, non-kidney health care professionals
often seemed similarly unaware of the relation be-
tween itch and kidney disease, potentially resulting
in ineffective treatment (e.g., treating it as a mere
skin condition).
Lack of Knowledge of Treatment Options. Despite real-
izing that itch was a consequence of having CKD, pa-
tients refrained from reporting itch to the kidney
team because they assumed there was no treatment
available; this emerged from both patient and health
care professional interviews.
Interviewer: ‘Have you ever discussed itch with the renal
team?’ Participant ‘No [laughs], you just think that there’s
nothing they can do about it. (PCe20, female, 58 years,
transplanted)
In addition, nephrologists considered itch a
difficult-to-treat symptom, which may have contrib-
uted to their reluctance to bring up itch in conversa-
tions with patients.
Is there a utility in acknowledging the importance of a
symptom during the consultation even if it’s not something
that I can treat? Maybe [discussing itch] does put me off
but I don’t think it’s necessarily without value. (CLe04,
male, consultant, 15 years clinical experience)
Some health care professionals mistakenly assumed
that itch was caused by poor phosphate control, and
included phosphate binders as part of their symptom
management strategy.Attitudes Toward the Importance of Itch as a Health
Issue
Patients’ Attitudes. Both patients and health care pro-
fessionals acknowledged that itch could have a sub-
stantial impact on patients’ sleep, and social and
emotional well-being. However, patients said that the
time they had with their nephrologist was too limited
to discuss all ongoing health issues, thereby leaving
itch unreported.
Table 2
Illustrative Quotations by Theme
Subtheme Quotations
Knowledge on causes and treatment of itch
Lack of awareness
of the relationship
between itch and
CKD
Patients
‘‘I went to my own GP [.] but [.] she didn’t relate it to [my kidney disease]. She just put it down to like, oh, you’re itching.’’
(PCe04, male, 72 yrs, dialysis)
Health care professionals
‘‘Many of them, umm, either don’t refer to it at all to us, or go to the GP, because they often feel that it’s not related to their kidney
problem.’’ (CLi01, male, consultant, 23 yrs clinical experience)
Lack of knowledge on
treatment options
Patients
‘‘If the kidney failure is causing the itching there’s nothing I can do about it, there’s nothing they can do about it; they can give me
something to. to ease the pain and, you know, they ease the itching; which it hasn’t helped so far, so I’ve just got to get on
with it.’’ (PLi06, female, 77 yrs, CKD Stages 1e5)
Health care professionals
‘‘When I’ve asked patients why they haven’t brought it up they’ll say: ‘Well, I didn’t think you could do anything about it’.’’
(CLi02, female, consultant, 17 yrs clinical experience)
‘‘[My approach to treating itch is] redoubling efforts on dialysis adequacy and phosphate’’ (CLe04, male, consultant, 15 yrs
clinical experience)
Attitudes toward the importance of itch as a health issue
Patients’ attitudes Patients
‘‘It got me down to the point, you know [.] I’d do anything to try and stop the itching, um, and it was becoming an obsession.’’
(PLi04, female, 69 yrs, CKD Stages 1e5)
‘‘It’s not one of the utmost or the foremost of people’s thoughts, an itch is just an itch [.] It’s not, like, ehmm, passing blood or I
couldn’t move or I couldn’t walk, ehmm, I was in that much pain, I couldn’t sleep, you know, it’s just an itch.’’ (PCe13,
male, 41 yrs, transplanted)
‘‘Each time I went to the hospital, they said they would try something else. That the doctor gave me something for the itch, it didn’t
work, cetirizine, I think. And then I went back to the hospital last Thursday, and she said she’s going to recommend using
Gabapentin. [.] That didn’t work.’’ (PLi06, female, 77 yrs, CKD Stages 1e5)
‘‘It does bother me but I just don’t. I’ve just never mentioned it and say I’m itching you know. [.] Just at my age put up with
things.’’ (PCe07, female, 80 yrs, dialysis)
Health care professionals
‘‘I guess if you’ve got an itch and you can’t sleep and you get tired and you get a low mood then in actual fact that is hugely
significant really.’’ (CLe05, male, consultant, 5 yrs clinical experience)
‘‘That’s typically true of patients on dialysis where so many other symptoms are more bothersome [than itch]and tend to take
precedence in management over management of itch.’’ (CMa02, female, consultant, 12 yrs clinical experience)
Health care
professionals’
attitudes
Patients
‘‘I think it’s pretty low down their list of important things [.]. They are extremely busy.’’ (PCe08, female, 68 yrs, dialysis)
‘‘I did say [to the nephrologist] that I was very itchy [.], but it wasn’t [pause] a big issue to her really.’’ (PCe06, female,
65 yrs, dialysis)
‘‘Whilst I can’t thank the renal team enough for everything that they’re doing for me, I do think that they at times have been
slightly dismissive of, you know, subjective reports of things like itches.’’ (PCe16, male, 60 yrs, transplanted)
Health care professionals
‘‘I don’t actively ask about itch. I wait for patients to mention it themselves [.] in the grand scheme of things, I guess [pause] it’s
not one of the priorities, rightly or wrongly, when I’m assessing someone with advanced CKD.’’ (CLe02, male, consultant,
14 yrs clinical experience)
‘‘I suppose some patients will just feel stupid, saying, I’m itchy. It doesn’t feel like something you should be telling your doctor,
compared to the bigger things. You wouldn’t really go to your doctor and say: ‘I’m itchy’, unless it was driving you seriously
bonkers.’’ (Nurse, focus group #3)
Prompts for itch assessment during consultations
Routine practice Patients
‘‘I had to tell them. I said: ‘I’ve got this itch’.’’ (PLi03, male, 74 yrs, CKD Stages 1e5)
‘‘They [the renal nurses] always ask about it when I attend the clinic.’’ (PLi05, female, 72 yrs, CKD Stages 1e5)
Health care professionals
‘‘I don’t think we’re at the point where. either in an outpatient clinic or during the dialysis session I don’t think it forms part of
the standard question to the patient.’’ (CLi04, male, consultant, 15 yrs clinical experience)
‘‘Itch would be definitely one of my routine questions.’’ (CMa02, female, consultant, 12 yrs clinical experience)
Itch as a marker Health care professionals
‘‘Interviewer: ‘Is itch something that you directly ask about? Nephrologist: ‘Yes, I do, especially in pre-dialysis clinic because I
consider it a marker of the uraemia.’’ (CLe10, male, consultant trainees, 4 yrs clinical experience)
‘‘I would bring [phosphate] up as an excuse to be able to try to link a symptom [itch], which somebody might have, with a goal
which I’m trying to achieve [.] which is actually the phosphate.’’ (CLi04, male, consultant, 15 yrs clinical experience)
Itch severity Patients
‘‘Sometimes I don’t ask about stuff, sometimes I just put up with things [.] and then, umm, obviously it gets worse, so then I’ve
got no choice, I . you know, to . to say to somebody.’’ (PCe05, male, 58 yrs, dialysis)
‘‘Interviewer: ‘Why did you think that the GP was the right person to talk about your itch?’ Patient: ‘Well, er, I. I think it was
more a matter of timing, than anything else [.] I happened to have a GP appointment, and, and I was being particularly
bothered at that time’.’’ (PCe08, female, 68 yrs, dialysis)
Health care professionals
‘‘Most patients don’t report themselves, okay? [.] but when you ask them, most of them say: ‘yeah, I do suffer from itching’. The
people that have very severe itch, of course, they volunteer and they ask for help.’’ (CLi01, male, consultant, 23 yrs clinical
experience)
‘‘I think there probably is a tendency to dismiss it as not necessarily as important unless it’s been a real problem in the few days
before.’’ (CLe08, female, consultant, 4 yrs clinical experience)
CKD ¼ chronic kidney disease; GP ¼ general practitioner.
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much to talk about that it isn’t something that has come up
in recent times. (PCe08, female, 68 years, dialysis)
This was in line with health care professionals sug-
gesting that patientsdespecially those on dialysis or
with multimorbiditydmight engage in a process of
prioritizing symptoms in which discussing other,
more worrisome, symptoms prevailed.
If somebody is struggling with their health in some of the,
as you say, life threatening or [.] something else concrete
and I could imagine for everybody [itch] slips down their
agenda. (CLe04, male, consultant, 15 years clinical
experience)
Many patients who prioritized other health issues
during consultations said they had come to accept
itch as something they had to live with; an attitude
that might have been reinforced by health care
professionals.
[The nurse] sort of advised me: ‘well, when your kidney
functions go down you get problems like that’. I think it
was like an acceptance these things happen, and just let
me know that, you know, that’s what to expect. (PLi12,
male, 55 years, dialysis)
Other reasons for this accepting attitude included
seeing itch as something trivial, a history of unsuccess-
ful treatments, or fear of being prescribed additional
medications.
Health Care Professionals’ Attitudes. Also, health care
professionals described how they dismissed the impor-
tance of itch in favor of other symptoms and health is-
sues. They acknowledged that their attitudes toward
itch or symptoms in general might have influenced
whether or not patients brought it up during the
consultation. Some argued that patients may censor
themselves because they anticipate that their nephrol-
ogist finds other issues more important; does not
consider itch worth discussing; or will not take them
seriously.
A fair number of people mention [itch], but then perhaps
move on to other things that either they think are more
important or they think that I will think are more impor-
tant. (CLe08, female, consultant, four years clinical
experience)
This was confirmed in the patient interviews, where
people said they had noticed that health care profes-
sionals did not consider itch a priority, or were more
interested in the objectively measured aspects of CKD.
The impression I get is that the renal team see a patient like
me that’s had no changes or fluctuation of body chemistry
since the transplant, the drugs are stable, the graft isworking well, therefore why would you consider getting
involved in any other issues? (PCe17, male, 32 years,
transplanted)Prompts for Itch Assessment During Consultations
Routine Practice. From both patients’ and health care
professionals’ accounts, it was apparent that symptom
assessment practices varied widely between health care
providers. Whereas many patients said they had to
raise the issue themselves, others were routinely asked
at clinic visits. And despite most renal nurses and ne-
phrologists being aware of itch remaining unreported,
many expected patients to bring it up, with only a few
saying they would systematically ask about it.
I’ve got the script I’ve got to get to the end of and I hope I
give the patients enough time to get to [.] at least a fair
amount of whatever their script is. [.] I don’t bring that
up as a specific ‘do you itch?’, with a patient. So, that’s
nowhere on my list at all. (CLe04, male, consultant,
15 years clinical experience)
At the same time, patients expected members of the
kidney team to raise the issue:
Probably from my point of view, it would be a good idea if
the consultants just listed that as one of the questions they
ask. (PCe08, female, 68 years, dialysis)Itch as a Marker. Several nephrologists considered
itch as a marker of uremia and therefore asked about
the symptom in pre-dialysis settings to inform the de-
cision whether to start dialysis.
In a dialysis population, it wouldn’t be one of the questions
that I would routinely ask actually, because I guess prob-
ably I would view itch in a pre-dialysis setting as, you
know, a sign that people may need to start dialysis.
(CLe05, male, consultant, 5 years clinical
experience)
Health care professionals who thought itch was
caused by high serum phosphate levels discussed the
symptom as part of a strategy to motivate patients to
better manage their phosphate.
Itch Severity. Patients and health care professionals
suggested that itch might only be discussed after
reaching a certain level of severity; for example,
when resulting in sleep deprivation or skin damage.
If it stops me sleeping, I would tell them (PLi01, male,
80 years, dialysis)
Furthermore, patients indicated that itch severity
fluctuated over time. And as periods of severe itching
did not always coincide with seeing the nephrologist,
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fessionals, such as their GP or renal nurses. In addi-
tion, health care professionals suggested that
patients may not recall being itchy when visiting the
renal unit if the symptom was not bothering them at
the time.
By the time they get to us, they might have forgotten that
they’ve got this itch, and they’re only with us for a short
duration, four hours. (Nurse, focus group #3)Discussion
Summary of Findings
We interviewed 25 CKD patients and 22 kidney
health care professionals to explore why uremic pruri-
tusdor itchdis not discussed between patients
and their kidney team, therefore risking under-
identification and suboptimal management. Reasons
for underreporting were related to the following:
knowledge of causes and treatment of itch; attitudes
toward the importance of itch as a health issue; and
prompts for itch assessment during consultations.
Our findings provide clear pointers for how to
improve itch reporting and management.
Relation to Other Studies
Our findings overlap with those of a qualitative
study from the U.S. by Flythe et al. of views on symp-
tom experiences and reporting of 42 hemodialysis pa-
tients and 13 dialysis nurses and technicians.32 This
suggests that some reasons for underreporting may
be similar across symptoms, disease stages, treatment
modalities, and health care professionals, such as
lack of knowledge on what causes symptoms and
how to manage them; seeing symptoms as an unavoid-
able consequence of kidney disease; dismissive atti-
tudes from health care professionals; competing
health issues and professional demands; and health
care professionals expecting patients to bring symp-
toms up during a consultation. Related to the latter,
our study additionally found that patients also ex-
pected health care professionals to ask about symp-
toms, and that they assumed the absence of a
clinician’s prompt to imply that symptoms did not war-
rant discussion.
Inclusion of nephrologists and non-dialysis CKD pa-
tients in our sample may explain why some of the rea-
sons in our ‘‘prompts for itch assessment’’ theme were
not identified by Flythe et al. For example, we found
that itch might remain undiscussed if it is not severe
at the time of the clinic encounter. This is more likely
in people who have an outpatient visit every three
months, compared with those who come to the dialysis
unit three times a week. We also identified variation inwhether and how symptoms were assessed, which may
indicate that the role of symptoms in disease manage-
ment differs between stages of CKD severity and types
of health care professionals.
Relation to Theory
We used the CSM of self-regulation as the theoret-
ical framework to guide data collection and analysis.
It poses that people’s beliefs about their illness (i.e.,
illness representations) enables them to make sense
of symptoms, and that this affects coping strategies,
which in turn impacts on health outcomes.28,29 Not re-
porting symptoms may reflect a negative or passive-
avoidant coping strategy. Therefore, to support
patients adopt more positive coping strategies to
improve their symptom burden, quality of life and
other outcomes, we should address reasons for under-
reporting that are related to people’s illness
representations.
One reason for underreporting identified in our
study was patients’ lack of knowledge on the relation
between CKD and itch. This links to CSM’s cause
component, which refers to people’s individualistic
ideas about the perceived cause of a condition. CSM
proposes that enhancing this knowledge would
improve ability to self-regulate, and thus the likeli-
hood that people will engage in self-reporting as
part of an active coping approach.28 The latter may
also be achieved through strengthening patients’ be-
liefs that itch could be controlled (CSM’s controllability
component), for example, through an intervention
that prompts health care professionals to ask about
itch and suggests recommended treatments. This
would avoid the impression that itch is untreatable
and thus not worth discussing.
Implications for Clinical Practice
We suggest three ways to improve reporting and
management of itch, and also of CKD symptoms
more generally.
Include Information on Symptoms in Pre-Dialysis Education.
Although symptoms are often mentioned in patient
information on CKD,33,34 they may be absent in mate-
rials that inform people on dialysis and other forms of
kidney replacement therapy (KRT).35 As KRT does not
always relieve itch and other symptoms, this absence of
information negatively affects patients’ awareness that
some symptoms may be related to CKD and its treat-
ment. Including symptom information as part of pre-
KRTeducation may enhance this understanding23,33,36
and thereby the likelihood that people will discuss
their symptoms with others.
Develop Clinical Practice Guidelines on Itch Management.
Not knowing how to treat itch led health care
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sing it in consultations. Some tried to manage itch
by lowering phosphate levels, but no randomized
controlled trials have been conducted to evaluate
the effectiveness of this strategy, nor have large obser-
vational studies confirmed an association between
elevated phosphate levels and itch.12 However, there
is sufficient evidence available on other treatments to
warrant development of clinical practice guidelines
on itch management.16,33 If successfully developed
and implemented,37 such guidelines would likely
improve knowledge among health care professionals
of evidence-based treatment options.
Incorporate Systematic Symptom Assessments into Kidney
Routine Care. We found that clinical practice of
itch assessment varied widely. Incorporating system-
atic symptom assessments into care would reduce
this variation and prompt shared decisions between
patients and professionals about symptom manage-
ment. Routine symptom assessments have been
advocated by many others23,32,33,38e41 based on evi-
dence that it enhances identification of problems
and patient-clinician communication, reduces symp-
tom burden and distress, and improves quality of
life.42,43
Proposed ways include the use of validated question-
naires,44,45 electronic data collection,38 and incorpo-
rating feedback of results within existing clinical
systems.36 To support health care professionals with
making sense of symptom information quickly, scores
could be combined with contextual information, such
as laboratory results, or with alerts to indicate which
symptoms require most attention.36 Our findings sug-
gest that pre-dialysis might be a suitable context to
initiate this practice change because health care pro-
fessionals often already consider symptoms when
deciding whether to start KRT.46 Local initiatives
aimed to implement systematic, electronic symptom
assessments in CKD care have been reported,47e49
but further efforts are warranted to achieve this at a
larger scale.Strengths and Limitations
To our knowledge, this is the first in-depth qualita-
tive study to investigate reasons for underreporting
of itch among people with CKD across stages and
treatment modalities. Interviewing both patients and
health care professionals, and triangulating perspec-
tives between them, increased our understanding of
the complexity of the symptom reporting process,
such as reciprocal expectations for the other party to
raise itch as an issue. This enabled us to provide clear
pointers for how to facilitate the reporting process andimprove management of itch and potentially other
symptoms.
A limitation of our study is that our participants
were predominantly white British and all able to
speak English, which hampered investigating cul-
tural and language barriers as a reason for underre-
porting. In addition, we might not have captured
the full range of experiences with regard to itch re-
porting patients and health care professionals in
our study were likely to be aware of itch as a symptom
of CKD and to perceive it as a topic that is worth dis-
cussing. Although we do not anticipate that recruit-
ing participants with a wider range of experiences
and perspectives would have resulted in different
themes, we might have been able to add more depth
to the themes related to ‘‘knowledge on causes
and treatment’’ and ‘‘attitudes toward importance
of itch.’’Conclusion
Underreporting of itch is related to patients’ lack of
awareness of its link with kidney disease, and to their
acceptance of itch as something they have to live
with. Furthermore, the length and timing of consulta-
tions may lead them to prioritize other health issues.
Health care professionals’ assessment and manage-
ment strategies vary widely and are not necessarily
evidence-based. Better patient information, develop-
ment of clinical practice guidelines, and incorporating
systematic symptom assessments into care may
improve itch reporting and management in people
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Additional Illustrative Quo
Subtheme
Knowledge on causes and treatment of itch
Lack of awareness
of the relationship
between itch and
CKD
Patients
‘‘[During the pre-dialysis meetings] they were discuss
but they never discussed itching.’’ (PLi12, male,
‘‘I didn’t know [itch] had anything to do with the ki
1e5)
Clinicians
‘‘I also think a lot of renal patients are not aware t
them.’’ (CLi02, female, consultant, 17 yrs clin
‘‘Most patients, by the time they say to us they’ve got it
by the GP with antihistamine tablets.’’ (CLi01, m
‘‘I would think that they just try and go to their GP
(CMa02, female, consultant, 12 yrs clinical e
Lack of knowledge
on treatment
options
Clinicians
‘‘Because itchiness is very difficult [to treat]. first o
then, to try and treat it symptomatically.’’ (CMa0
‘‘I have to say, I find it not an easy symptom to treat [
date [.] I’ve very rarely used things like gabape
‘‘Antihistamines [.] I don’t find that they’re necess
‘‘It is recognised that a raised phosphate level can be
would get dietetic advice regarding reduced phosp
‘‘[Itch] is more important now, now that we know t
Attitudes toward importance of itch as a healt
Patients’ attitudes Patients
‘‘[I am embarrassed] because if you’re itching and t
72 yrs, dialysis)
‘‘[I did not report it because] I thought it was a triv
‘‘An itch is just an itch.’’ (PCe13, male, 41 yrs, t
‘‘I just kind of . I’ve got to the stage where I just t
transplanted)
‘‘Interviewer: ‘Have you mentioned itch to your nephr
pills already, I’m frightened that if I go and say, so
CKD Stages 1e5)
Clinicians
‘‘I’d say itch is quite important because you see the d
scratching all the time they’re like different people
‘‘It is important because [.] it is one of the symptom
clinical experience)
‘‘Patients don’t only require one drug, you know, they
during the day, they are overwhelmed by all issues
something else rather than the itching.’’ (CLe10,
Clinicians’ attitudes Patients
‘‘[The nephrologist] said: ’Well, don’t worry about i
‘‘I thought: ‘Well it [itch] mustn’t be serious becaus
female, 65 yrs, dialysis)
‘‘I think here they care creatinine levels more than it
‘‘I think it was viewed as quite a minor thing, reall
male, 60 yrs, transplanted)
Clinicians
‘‘If you look at the priorities [.] nobody dies of itch.
and the ankles that, you know, the nursing staff
experience)
‘‘As a symptom it is part of a list of things which are p
male, consultant, 15 yrs clinical experience)
‘‘I’m more interested in weight loss, appetite, nausea
consultant, 14 yrs clinical experience)
‘‘I think it’s quite easy to get focused on the things tha
severe itching is a very intrusive.’’ (CLe08, fem
‘‘It’s very problematic for patients but I think a lot of
or don’t think it’s a problem.’’ (CLi02, female,
‘‘I think any symptom management is very relevant. A
embarrassing, and uncomfortable during the day
(CMa01, female, consultant, 31 yrs clinical eable 1
tations for Each Theme
Quotations
ing. like showing you all the various things [different options of dialysis],
55 yrs, dialysis)
dneys but I was certainly never told.’’ (PLi08, female, 77 yrs, CKD Stages
hat it’s a problem to do with their renal failure, partly because we don’t tell
ical experience)
ching, they’ve tried various creams and things, quite often they’ve been treated
ale, consultant, 14 yrs clinical experience)
and try and see if they can manage with, you know, the various creams.’’
xperience)
f all, you need to find out what is the cause of the itching, if you can do. And
1, female, consultant, 31 yrs clinical experience)
.] Maybe I’m missing out somewhere [.] maybe I need to be a bit more up to
ntin.’’ (CLi01, male, consultant, 23 yrs clinical experience)
arily useful.’’ (CMa02, female, consultant, 12 yrs clinical experience)
associated with itchiness. We have a dietitian resident in our clinic, so they
hate intake.’’ (CMa01, female, consultant, 31 yrs clinical experience).
here’s something that can be done about it.’’ (nurse, focus group #1)
h issue
hings people think: ‘Oh, is he dirty? Has he got scabies?’.’’ (PCe04, male,
ial symptom not worth mentioning.’’ (PLi01, male, 41 yrs, dialysis)
ransplanted)
hink it’s one of those things that I’ll just live with.’’ (PCe17, male 32 yrs,
ologist recently?’ Patient: ‘Only the first time [.] Because I’m taking so many
mething else is, is happening, that’s another pill’.’’ (PLi05, female, 72 yrs,
ifference once they’ve been treated . because they’re sleeping and they’re not
.’’ (nurse, focus group #1)
s that impair quality of life of dialysis.’’ (CLi01, male, consultant, 23 yrs
require several [.]. So, [.] perhaps that symptom [itch] is not as constant
regarding the uraemia [.]. They would be, perhaps, more afraid to dying of
male, trainee nephrologist, 4 yrs clinical experience)
t’, and that was his answer.’’ (PLi10, female, 89 yrs, dialysis)
e I’ve never been talked serious’, but it is sometimes quite bad.’’ (PCe06,
ching.’’ (PCe13, male, 41 yrs, transplanted)
y. [.] they think: ‘Well, you’ve got bigger things to think about’.’’ (PCe16,
[.] the quality of life issue is a big problem, but [.] it’s not the breathing
would talk about.’’ (CLi02, female, consultant, 17 yrs clinical
robably more important to the patient than they are to their doctors.’’ (CLe04,
, vomiting, and other kinds of uraemic symptoms.’’ (CLe02, male,
t I perceive as potentially life threatening and forget that actually [hesitation]
ale, consultant, 4 yrs clinical experience)
doctors and. or health care professionals in general don’t tend to bring it up
consultant, 17 yrs clinical experience)
nd itching is something that can stop people sleeping. And, obviously be very
[.] we’re trying to symptom manage, and improve their quality of life.’’
xperience)
(Continued)
Appendix Table 1
Continued
Subtheme Quotations
‘‘And for trainees, I think they don’t get brought up to recognise that actually itch is a significant [.] the same for renal nurses.’’
(CLi02, female, consultant, 17 yrs clinical experience)
‘‘I guess it depends on how willing both parties are to space to talk about that sort of thing and because with the space I suspect it
comes out and without the space it’s probably not on the list of things which the patient thinks the doctor’s going to be interested
in.’’ (CLe04, male, consultant, 15 yrs clinical experience)
Prompts for itch assessment during consultations
Routine practice Patients
‘‘They just ask me the standard questions: ‘Are you still itchy?’, and I’ll put, yes, and they suggest things’.’’ (PLi07, male, 48 yrs,
CKD Stages 1e5)
Clinicians
‘‘It’s not something that’s formalised. It’s not that I’ve got a checklist that I tick off or that we have a pro forma or a symptom
scoring.’’ (CLe01, male, consultant, 23 yrs clinical experience)
‘‘We ask every time we see the patient in an out-patient setting, we ask them about itching [.] and we ask them to grade it as well.’’
(CLi01, male, consultant, 14 yrs clinical experience)
‘‘I think for patients it’s a major issue and I think a lot of patients would welcome it. How this would fit in in my everyday care? but
then my everyday care might be very different from everyday care of another clinician, just because I’m acutely aware it’s an
issue.’’ (CLi02, female, consultant, 17 yrs clinical experience)
‘‘My standard approach in clinic is to ask the patient how they’re doing and then if they don’t volunteer any symptoms, to run
through very quickly a list of symptoms that they might have, tiredness, breathing difficulty, changes in appetite, er, nausea,
vomiting, changes in taste, itching. Now, I’m not saying I do that with every single patient, but if the patient, er, either doesn’t
report any symptoms or, um, says they feel well, I usually try to elicit [.]in the pre-dialysis clinic. Whereas I wouldn’t normally
do it in the general nephrology clinic, because I suppose my prejudice is that I won’t find . most of these patients won’t have
these symptoms.’’ (CLe01, male, consultant, 23 yrs clinical experience)
‘‘I think most of us are acutely aware that itch is a big problem with patients and most of them won’t bring it up.’’ (CLi02, female,
consultant, 17 yrs clinical experience)
‘‘A small number of patients voluntarily report it as a very troublesome symptom. Other patients report it as a symptom, but I’m sure
where you actively seek it as a symptom, you will probably find other patients who don’t volunteer it.’’ (CLi01, male,
consultant, 23 yrs clinical experience)
Itch as a marker Clinicians
‘‘Itching is something that I will [talk about] [.] in a pre-dialysis setting, particularly when I’m discussing at what point patients
might need dialysis [along with] appetite, nausea, vomiting, generalised itching, all of the kind of uremic symptoms.’’ (CLe08,
female, consultant, 4 yrs clinical experience)
Itch severity Patients
[Itch] comes and goes, ehmm, sometimes it is particularly bad, stops you sleeping.’’ (PCe17, male, 32 yrs, transplanted)
‘‘It would give up a bit, you know, then it has come back again and, you never had many days of peace.’’ (PLi03, male, 74 yrs,
CKD Stages 1e5)
‘‘The only reason why I got treated is because it was visual, you could visually see the skin was broken.’’ (PCe13, male, 41 yrs,
transplanted)
‘‘You deal with the nurses mostly, and the consultant only comes in if they’re a bit unsure on anything. [.] We don’t really see the
consultant very often, do we?, unless it’s an emergency, or I’m in a lot of pain [.] maybe once a year, twice a year.’’ (PLi07,
male, 48 yrs, CKD Stages 1e5)
Clinicians
‘‘Very often they don’t [report itch], and when they do, you can actually see evidence of scratch marks on their physical body, and I
think you then ask: ‘Have you been scratching yourself?’, that’s when they probably start with the story of the itch.’’ (CMa02,
female, consultant, 12 yrs clinical experience)
CKD ¼ chronic kidney disease; GP ¼ general practitioner.
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